EMD
Click for more information
3.57% 5.4¢ emyria limited

An MDMA analogue which could end up in direct competition with...

  1. reon1
    1,406 Posts.
    lightbulb Created with Sketch. 447
    clock Created with Sketch.
    20/06/24
    09:01
    Post #: 74402338
    An MDMA analogue which could end up in direct competition with Emyria's own ones. Very strange.

    All to generate some professional fees. Emeryia has changed so much from a promising biotech to a clinical service provider.
    Last edited by reon1: 20/06/24
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

A1M Swagman shoot proves plentiful for AIC, with Cu beyond 3% close to Eloise
right-arrow Created with Sketch.
ARU Cashed up Arafura locks in $171M German export agency deal; locks in NdPr offtake for wind turbines
right-arrow Created with Sketch.
NEWS Finding properties tenants will want to rent
right-arrow Created with Sketch.
ALK Alkane Resources hit 57.2Kozpa gold production through FY24 – and eyeing 70Ktpa in FY26
right-arrow Created with Sketch.
AHK Ark Mines defines significant exploration target at Sandy Mitchell rare earths project
right-arrow Created with Sketch.
watchlist Created with Sketch. Add EMD (ASX) to my watchlist
(20min delay)
Last
5.4¢ 		Change
-0.002(3.57%) 		Mkt cap ! $22.08M
Open High Low Value Volume
5.6¢ 5.6¢ 5.4¢ $1.283K 23.76K

Buyers (Bids)

No. Vol. Price($)
1 41242 5.4¢
 

Sellers (Offers)

Price($) Vol. No.
5.6¢ 51333 2
View Market Depth
Last trade - 11.27am 05/07/2024 (20 minute delay) ?
EMD (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.